Benefits
Blood Sugar Regulation
The one study cited on this page is a 2020 systematic review that pooled 28 randomized trials, and every participant in it had diagnosed type 2 diabetes. In that pooled analysis chromium lowered fasting plasma glucose by about 19 mg/dl, HbA1c by about 0.71 percentage points, fasting insulin by about 12 pmol/l and a measure of insulin resistance called HOMA-IR by about 1.53. The authors worded their own conclusion cautiously, saying the results might support chromium use for blood sugar control in people with type 2 diabetes. That is research in people who already have a diagnosed disease, so it does not show what chromium does for a healthy person's blood sugar, and chromium is not a treatment for diabetes. If you take insulin or any other glucose-lowering medication, talk to your doctor first, because adding something that lowers blood sugar on top of medication that lowers blood sugar can push you too low.
Metabolism Support
Chromium is involved in how the body handles carbohydrates and fats through its effect on insulin signaling. That is textbook nutrition biochemistry rather than a measured benefit: no study cited on this page measured energy use, metabolic rate or nutrient handling in people.
Weight Management
Chromium is heavily marketed for weight loss and appetite control, but nothing cited on this page supports that. The single reference here looked only at blood sugar markers in people with type 2 diabetes and did not measure body weight, body fat or appetite at all.
Cholesterol Levels
No study cited on this page measured cholesterol. The single reference here reviewed blood sugar outcomes in people with type 2 diabetes, so this page has nothing to support a cholesterol or heart health benefit.
Polycystic Ovary Syndrome (PCOS)
Nothing cited on this page addresses polycystic ovary syndrome. The single reference here enrolled people with type 2 diabetes and reported blood sugar markers only. PCOS is a medical condition that needs a doctor, and no supplement should be presented as a treatment for it.
Mechanism of action
Insulin Sensitization
The proposed mechanism is that chromium supports insulin signaling and helps move the glucose transporter GLUT4 to the cell surface, which would improve glucose uptake. This comes from laboratory work, not from the human study cited on this page.
Metabolic Regulation
Chromium is thought to form part of a molecule called chromodulin, which may amplify insulin’s effects on carbohydrate, fat, and protein metabolism.
Lipid Metabolism
One proposed mechanism is that chromium influences enzymes involved in cholesterol production. This is theory only, and no cholesterol result is reported in the single study cited on this page.
Clinical trials
Randomized controlled trial of chromium picolinate (200 µg/day) vs placebo in 52 T2DM patients over 12 weeks. Outcomes: fasting glucose, HbA1c, lipid profile, insulin resistance. (Clin Nutr Res)
52 T2DM patients. 12-week intervention.
This trial is not among the references listed on this page, so its numbers cannot be verified here. What the page can actually support comes from its one reference, a 2020 pooled analysis of 28 randomized trials in people with type 2 diabetes, which reported lower fasting glucose and HbA1c but did not report cholesterol outcomes at all. The lipid claim in this card is therefore unverified, and any effect described here was seen in people with a diagnosed disease, not in healthy adults.
Randomized controlled trial of chromium-enriched yeast (400 µg/day chromium) vs placebo in 36 insulin-treated T2DM patients over 12 weeks. Outcomes: fasting plasma glucose, HbA1c, insulin requirements, lipid profile.
36 insulin-treated T2DM patients.
This trial is not among the references listed on this page, so its results cannot be verified here. It was also very small, 36 people. Nothing cited here compares chromium-enriched yeast head to head against chromium picolinate, so the suggestion that one form is better than the other is not supported. Anyone using insulin should never adjust their dose because of a supplement without their doctor.
Pooled analysis of 23 clinical trials examining chromium supplementation effects on cardiometabolic outcomes (glucose, HbA1c, lipids, blood pressure) with a dose-response analysis. (Wan et al. 2023, JACC Adv) This analysis is not among the references listed on this page, so it could not be verified here.
Pooled across 23 clinical trials.
In T2DM patients, chromium doses ≥400 µg/day significantly reduced fasting plasma glucose (WMD: -0.67 mmol/L) and HbA1c. Lower doses showed minimal effects, and in people without diabetes the effects were not statistically significant. That null result matters: it means the pattern here matches the one study this page does cite, where the benefit was seen in people with diagnosed type 2 diabetes and not in healthy people. Because this analysis is not among the page's references, its specific numbers cannot be checked here.
Evidence review and pooled analysis of 11 clinical trials through assessing chromium supplementation effects on systolic and diastolic blood pressure. (Eur J Clin Nutr)
Pooled across 11 clinical trials.
This is a null result: no meaningful effect on systolic or diastolic blood pressure overall. Chromium should not be taken for blood pressure. A subgroup hint inside an otherwise negative analysis is a hypothesis, not a finding. This review is also not among the references listed on this page, so it could not be verified here.
Randomized controlled trial in 26 older adults (mean age ~65) with early memory decline receiving chromium picolinate (1,000 µg/day) vs placebo for 12 weeks. fMRI imaging and cognitive testing. (Nutr Neurosci)
26 older adults with early memory decline. 12-week intervention.
This trial is not among the references listed on this page, so it could not be verified here. It was also very small, just 26 people, it was run in older adults who already had memory decline rather than in healthy people, and it has not been repeated. It is not a reason to take chromium for memory, and no cited evidence on this page supports a brain or cognition benefit.